2018 World Premiere: a life-changing therapy for SCI patients

Subscription

Dr Decherchi's preclinical trial

Four basic stages must be passed before authorization for a clinical trial with NEUROGEL™can be granted. Once these steps have been taken, the gates to funding  will open.

STEP 1 : CONCLUSION OF DR. DECHERCHI’S PRECLINICAL (first half 2011)

To obtain authorization for a clinical trial, the Association first sponsored  Dr. Decherchi’s preclinical trial in Marseille. This study based on a combination of NEUROGEL™+ two hormones (EPO+progesterone.) is currently under completion ; results so far are encouraging.  This work will lead to an official publication during the first half of 2011.

STEP 2 : CONTRACT  SIGNATURE WITH A CONTRACT RESEARCH ORGANIZATION

The Association has also built ties with various contract research organizations, essential partners to create optimal conditions for a clinical trial and its follow-up.   Understandably, our goal today is to raise enough funds to hire the services of a CRO.  The most serious  sofar is MedPass International who has already put together a preliminary dossier for NEUROGEL™.

STEP 3 : TOXICOLOGY TESTS

Funding the required toxicology tests  to prove that NEUROGEL™ is not dangerous to humans is also a must.  Although Dr. Woerly already passed these tests, they must be repeated because the manufacture of  NEUROGEL™ has evolved.
In conclusion, we need 365,000 € to fund a contract research organization and conduct the toxicology tests that will lead to an authorization for a clinial tial.
To help the Assocation, donate here

STEP 4 : PREPARING AN APPLICATION FOR A CLINICAL TRIAL AUTHORIZATION

Pr. Woerly had obtained the authorization to conduct a clinical trial with le NEUROGEL™ from Quebec’s health authority.
 
To help us obtain an authorization to conduct a clinical trial from AFSSAPS,  a CRO (research organization under contract) will put up a complete dossier including the preclinical results, toxicology tests, publications and an action plan for the clinical trial.  Given all the regulatory requirements, this dossier must be produced by professionals specialized in running clinical trials. , whose services we must therefore be able to fund. We need 365,000 € to fund their services.

Help us speed up the application process by giving here.